Category: Include on Menu
-

Hormel Foods climbs 4% as upbeat fiscal 2026 outlook offsets softer Q4 results
Hormel Foods Corporation (NYSE:HRL) reported fourth-quarter results on Thursday that met expectations but were weighed down by sizable impairment charges. Still, shares rose 4% in pre-market trading as investors focused on the company’s stronger-than-expected fiscal 2026 guidance. The producer of Spam, Skippy, and Planters posted adjusted earnings of $0.32 per share, matching consensus estimates. Revenue…
-

Amazon said to be preparing to phase out USPS partnership as it expands delivery network
Amazon (NASDAQ:AMZN) is reportedly preparing to broaden its U.S. delivery infrastructure and unwind its long-running partnership with the U.S. Postal Service, according to a report from The Washington Post on Thursday. The newspaper, citing three individuals familiar with the discussions, said the e-commerce giant is moving toward handling a larger share of its own last-mile…
-

Genesco shares sink 12% as weak Schuh performance forces sharp guidance cut
Genesco Inc. (NYSE:GCO) saw its stock tumble 12.06% in pre-market trading on Thursday after the footwear retailer slashed its full-year outlook, overshadowing a third-quarter report that otherwise showed continued momentum in comparable sales. For the quarter, Genesco posted adjusted earnings of $0.79 per share on revenue of $616 million—missing analyst expectations of $0.88 per share…
-

Hapag-Lloyd reportedly submits offer for ZIM Integrated Shipping; shares climb 4%
Shares of ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) rose 4% on Thursday after Globes reported that German shipping heavyweight Hapag-Lloyd (TG:HLAG) has made a preliminary acquisition bid for the company. According to the report, the offer remains at an early stage, and formal negotiations have not yet begun. ZIM—currently the world’s ninth-largest container carrier with…
-

America’s Car-Mart rises 2% premarket as investors look past earnings miss and focus on capital overhaul
America’s Car-Mart (NASDAQ:CRMT) reported a wider-than-expected loss for its fiscal second quarter on Thursday, but shares still gained 2.06% in pre-market trading as investors emphasized the company’s ongoing capital restructuring efforts and improvements in its credit portfolio. The used car retailer posted an adjusted loss of $0.79 per share, sharply missing analyst expectations for a…
-

Wiley shares slip as Q2 revenue misses forecasts despite earnings outperformance
Wiley (NYSE:WLY) reported mixed second-quarter results on Thursday, beating profit expectations but falling short on revenue, which pushed its shares down 2.35% in pre-market trading. For the quarter ended October 31, the research and education publisher posted adjusted earnings per share of $1.10, topping the consensus estimate of $1.00. Revenue, however, totaled $422 million —…
-

Ekso Bionics jumps 20% after securing exclusive U.S. distribution rights for BalanceTutor system
Shares of Ekso Bionics Holdings Inc. (NASDAQ:EKSO) soared 20% on Thursday after the company announced a new agreement that makes it the exclusive U.S. distributor for MediTouch’s BalanceTutor rehabilitation system. Ekso Bionics — known for its medical and industrial exoskeleton technologies — will act as the authorized sales agent for the advanced balance-retraining solution across…
-

Rex American Resources posts strong Q3 beat as ethanol output remains robust
Rex American Resources Corp. (NYSE:REX) reported fiscal third-quarter 2025 results on Thursday that surpassed Wall Street expectations, delivering adjusted earnings per share of $0.71 — far above the consensus estimate of $0.27. Revenue came in at $175.6 million, also ahead of the projected $169 million. Shares of the ethanol producer rose 1.55% in pre-market trading…
-

Crescent Biopharma jumps 12% after unveiling Kelun-Biotech collaboration and $185 million financing
Crescent Biopharma (NASDAQ:CBIO) surged 12% on Thursday after announcing a new strategic alliance with Kelun-Biotech alongside a $185 million private placement aimed at accelerating its cancer drug pipeline. Under the partnership, Kelun-Biotech receives exclusive rights to develop Crescent’s PD-1 x VEGF bispecific antibody (CR-001) in Greater China. In return, Crescent gains exclusive access to Kelun-Biotech’s…
-

Inside Sekur’s push into sovereign encrypted communications
Hello, I’m Ricki Lee and this is the Capital Compass. Today we’re looking at Sekur Private Data (USOTC:SWISF) (CSE:SKUR). A company focused on sovereign encrypted communication at a time when cyber attacks on US agencies are accelerating. Just in the past few weeks, a federal breach exposed citizens contact information and signal experienced a major outage.…